Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway
- PMID: 1624807
Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway
Abstract
Eosinophil granules contain several cationic proteins that mediate tissue damage in allergic disease. The present study examined the capacity and mechanisms by which these cationic proteins regulate activity of the alternative pathway of C. Eosinophil peroxidase and eosinophil cationic protein inhibited formation of cell-bound alternative pathway C3 convertase, causing 50% inhibition of lysis at about 0.19 and 0.75 microgram/10(7) cellular intermediates, respectively. Major basic protein inhibited alternative pathway C3 activity by only 19% at 1.5 micrograms/10(7) cellular intermediates. Eosinophil-derived neurotoxin had no activity on the alternative pathway. The eosinophil granule proteins were examined for the mechanism by which they inhibited alternative pathway activity. Eosinophil peroxidase and major basic protein inhibited fluid phase factor B consumption in a reaction mixture that also contained factors D and C3b, eosinophil-derived neurotoxin had no activity on factor B consumption, and eosinophil cationic protein consumed factor B in the absence of C3b and factor D. Both eosinophil cationic protein and eosinophil peroxidase enhanced the decay of preformed alternative pathway convertase. Lysis of EAC4b,3b cellular intermediates formed to contain a low surface amount of C3b was more inhibited than was lysis of cells formed with a standard amount of C3b on the surface. This suggests that these eosinophil proteins acted predominantly on C3b to regulate alternative pathway activity. We also found that none of the eosinophil granule cationic proteins had any effect on later events after the formation of the C3 convertase. We conclude that although eosinophil-derived neurotoxin (isoelectric pH value (pI) = 8.9) does not regulate alternative pathway activity, the more highly charged eosinophil granule cationic proteins--major basic protein (pI = 10.9), eosinophil cationic protein (pI = 10.8), and eosinophil peroxidase (pI = 10.8)--do share the capacity to regulate C activity and may exert this activity in vivo.
Similar articles
-
Eosinophil granule cationic proteins regulate the classical pathway of complement.Immunology. 1995 Feb;84(2):213-9. Immunology. 1995. PMID: 7750997 Free PMC article.
-
Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.J Immunol. 1988 Mar 1;140(5):1605-10. J Immunol. 1988. PMID: 3346544
-
The inhibitory effect of factor J on the alternative complement pathway.J Biol Chem. 1994 Oct 21;269(42):26017-24. J Biol Chem. 1994. PMID: 7929312
-
The molecular biology of eosinophil granule proteins.Int Arch Allergy Appl Immunol. 1991;94(1-4):202-9. doi: 10.1159/000235362. Int Arch Allergy Appl Immunol. 1991. PMID: 1657792 Review.
-
[Biochemistry and biological activities of eosinophil granule proteins].Nihon Rinsho. 1993 Mar;51(3):605-12. Nihon Rinsho. 1993. PMID: 7684096 Review. Japanese.
Cited by
-
TNF-alpha mediates eosinophil cationic protein-induced apoptosis in BEAS-2B cells.BMC Cell Biol. 2010 Jan 20;11:6. doi: 10.1186/1471-2121-11-6. BMC Cell Biol. 2010. PMID: 20089176 Free PMC article.
-
Eosinophil granule cationic proteins regulate the classical pathway of complement.Immunology. 1995 Feb;84(2):213-9. Immunology. 1995. PMID: 7750997 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous